| |
| |
|
| Insider
Information: |
Fenton Mary Kay |
| Relationship: |
Chief Financial Officer |
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
70,554 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15,400 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
70,554 |
|
|
| Total
Value |
$15,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Achillion Pharmaceuticals Inc |
ACHN |
Chief Financial Officer |
2016-12-05 |
2,500 |
|
0 |
Premium* |
|
|
Tourmaline Bio |
TRML |
Chief Financial Officer |
2023-07-03 |
68,054 |
2021-12-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TRML |
Tourmaline Bio |
Chief Financial Officer |
• – – |
2023-07-03 |
4 |
D |
$3.08 |
$39,874 |
D/D |
(12,946) |
68,054 |
0 |
- |
|
| TRML |
Tourmaline Bio |
Chief Financial Officer |
• – – |
2022-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
81,000 |
0 |
- |
|
| TRML |
Tourmaline Bio |
Chief Financial Officer |
• – – |
2021-12-31 |
4 |
A |
$13.00 |
$13,000 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Chief Financial Officer |
• – – |
2016-12-05 |
4 |
B |
$4.11 |
$10,275 |
D/D |
2,500 |
2,500 |
2.74 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Chief Financial Officer |
• – – |
2015-12-28 |
4 |
S |
$10.08 |
$438,480 |
D/D |
(43,500) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Chief Financial Officer |
• – – |
2015-12-28 |
4 |
OE |
$1.05 |
$45,675 |
D/D |
43,500 |
43,500 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
EVP and CFO |
• – – |
2015-01-23 |
4 |
S |
$16.00 |
$210,000 |
D/D |
(13,125) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
EVP and CFO |
• – – |
2015-01-23 |
4 |
OE |
$4.00 |
$52,500 |
D/D |
13,125 |
13,125 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
SVP and CFO |
• – – |
2012-01-10 |
4 |
S |
$12.00 |
$127,500 |
D/D |
(10,625) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
SVP and CFO |
• – – |
2012-01-10 |
4 |
OE |
$1.60 |
$17,000 |
D/D |
10,625 |
10,625 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
SVP and CFO |
• – – |
2012-01-09 |
4 |
S |
$9.34 |
$40,863 |
D/D |
(4,375) |
0 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
SVP and CFO |
• – – |
2011-04-06 |
4 |
S |
$7.50 |
$1,043 |
D/D |
(139) |
4,375 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
SVP and CFO |
• – – |
2011-04-05 |
4 |
S |
$7.50 |
$30,833 |
D/D |
(4,111) |
4,514 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
SVP and CFO |
• – – |
2011-03-30 |
4 |
S |
$7.50 |
$30,000 |
D/D |
(4,000) |
8,625 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
SVP and CFO |
• – – |
2011-01-13 |
4 |
S |
$5.00 |
$43,750 |
D/D |
(8,750) |
12,625 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Vice President and CFO |
• – – |
2008-09-05 |
4 |
OE |
$1.60 |
$5,000 |
D/D |
3,125 |
21,375 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Vice President and CFO |
• – – |
2006-12-18 |
4 |
OE |
$1.60 |
$2,000 |
D/D |
1,250 |
1,250 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
Vice President and CFOOfficer |
• – – |
2006-10-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,000 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
